대한방사선기술학회지:방사선기술과학 (Journal of radiological science and technology)

  • 제36권3호
  • /
  • Pages.209-217
  • /
  • 2013
  • /
  • 2288-3509(pISSN)
  • /
  • 2384-1168(eISSN)
대한방사선과학회 (Korean Society of Radiological Science)
권호 표지

남성 근로자의 복부지방두께와 adiponectin, BDNF 및 leptin의 관련성

A Study on the Relationship between Adiponectin, BDNF and Leptin with Abdominal Fat Thickness in Male Workers

  • 고경선 (한국산업안전보건공단 산업안전보건연구원) ;
  • 최윤정 (한국산업안전보건공단 산업안전보건연구원)
  • Ko, Kyung-Sun (Center for Occupational Health Research, Occupational Safety and Health Research Institute, KOSHA) ;
  • Choi, Yoon-Jung (Center for Occupational Health Research, Occupational Safety and Health Research Institute, KOSHA)
  • 투고 : 2013.07.31
  • 심사 : 2013.09.09
  • 발행 : 2013.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

이 연구는 지방조직에서 분비되어 비만의 진행 조절에 관여하는 adiponectin과 leptin의 복부지방두께와의 관련성을 보고자 하였다. 연구대상자는 남성 근로자 138명으로 초음파를 이용하여 피하 및 내장지방두께를 측정하고 ELISA kit을 이용하여 adiponectin, BDNF 및 leptin의 농도를 측정하였다. 그 결과, 대상자의 평균피하지방과 내장지방두께는 $1.58{\pm}0.51$과 $4.52{\pm}1.44cm$이었다. Adiponectin, BDNF 및 leptine의 평균농도는 각각 $3.14{\pm}3.52$ ng/ml, $24.11{\pm}8.52$ pg/ml와 $4.27{\pm}2.38$ ng/ml이었다. 내장지방두께는 총 콜레스테롤, LDL-콜레스테롤, 중성지방 및 인슐린 농도와 양의 상관관계를 보였으나, HDL-콜레스테롤과는 음의 상관관계를 보였다. Adiponectin 농도는 HDL-콜레스테롤의 농도와 양의 상관관계를 보였고 총 콜레스테롤, LDL-콜레스테롤, 중성지방, 피하 및 내장지방두께와는 음의 상관관계를 보였다. 그러나 leptin의 농도는 adiponectin과 상반되는 결과를 보였다. Adiponectin의 농도는 비만하지 않은 대상자(BMI<25 $kg/m^2$)에서 유의하게 높았으나 leptin의 농도는 비만한 대상자((BMI>25 $kg/m^2$)에서 높았다. 비만과 adiponectin, BDNF 및 leptin의 관련성을 보기 위하여, 연령, 흡연 및 음주습관 등을 보정한 다음, 다중 로지스틱 회귀분석을 실시한 결과, 비만은 adiponectin(교차비=0.784, p=0.006)과 leptin(교차비=1.493, p=0.001)이 관련이 있는 것으로 나타났다. 이상의 결과는 adiponectin과 leptin의 농도가 복부지방에 영향을 주고, 이들 신경영양 물질들의 생성과 분비 기능저하는 궁극적으로 비만과 심혈관계 질환의 유발에 관여함을 보여준 결과라 판단된다.

Adiponectin (AdipoN), brain-derived nerotrophic factor (BDNF) and leptin (LeP) are mainly secreted from adipose tissue and are known to be involved in regulation of the development of obese. However, there are not many studies on the association between abdominal fat and neuropeptides such as AdipoN, BDNF and LeP. The aim of this study was undertaken to investigate the association between abdominal fat thickness, neuropeptides and cardiovascular disease (CVD) risk factors. The participants in the study were 138 male employees without CVD. This study was approved by the Institutional Review Board of Occupational Safety and Health Research Institute. Written informed consent for the participants in this study was obtained from all individuals. We obtained subcutaneous fat thickness (SFT) and visceral fat thickness (VFT) by using ultrasonography and neuropeptides levels were measured with ELISA kit according to the method suggested by kit manufacturer. The mean SFT and VFT were $1.58{\pm}0.51$ and $4.52{\pm}1.44$ cm. The mean concentrations of AdipoN, BDNF and LeP were $3.14{\pm}3.52$ ng/ml, $24.11{\pm}8.52$ pg/ml and $4.27{\pm}2.38$ ng/ml, respectively. VFT were positively correlated with total cholesterol (r=0.217, p<0.05), LDL-cholesterol (r=0.271, p<0.01), triglyceride (r=0.233, p<0.05) and insulin (r=0.338, p<0.01), but was inversely correlated with HDL-cholesterol (r=-420, p<0.01). AdipoN levels were positively correlated with HDL-cholesterol (r=0.220, p<0.05) and were inversely correlated with total cholesterol (r=-0.196, p<0.05), LDL-cholesterol (r=-0.190, p<0.05), triglyceride (r=-0.199, p<0.05), SFT (r=-0.195, p<0.05) and VFT (r=-0.412, p<0.01). However, LeP levels showed a reverse trend to AdipoN. AdipoN level was significantly higher in non-obese participants (BMI<25 kg/m), but LeP concentration was significantly higher in obese participants (BMI>25 kg/m) than in non-obese. On multiple logistic regression analysis, obese were significantly associated with AdipoN (odds ratio=0.784) and LeP (odds ratio=1.494). These results suggested that AdipoN and LeP concentrations are affected abdominal fat and that dysfunction and/or declination in the production and secretion of neuropeptides might induced ultimately obese and CVD.

키워드

참고문헌

  1. Prentice AM, Jebb SA : Beyonf body mass index, Obese Review, 2(3), 141-147, 2001 https://doi.org/10.1046/j.1467-789x.2001.00031.x
  2. Redman LM, Martin CK, Williamson DA, Ravussin E : Effect of caloric restriction in non-obese humans on physiological, psychological and behavioral outcomes, Physiology and Behavior, 94(5), 643-648, 2008 https://doi.org/10.1016/j.physbeh.2008.04.017
  3. Ogden CL, Carroll MD, Kit BK, Flegal KM : Prevalence of obesity in the United States, 2009-2010, Centre for Disease Control and Prevention (CDC), National Center for Health Statistics Data Brief, 82, 1-8, 2012
  4. Ogaden CL, Yanovski SZ, Carroll MD, Flegal KM : The epidemiology of obesity, Gastroenterology, 132(6), 2087-2102, 2007 https://doi.org/10.1053/j.gastro.2007.03.052
  5. Kumanyika S, Taylor WC, Grier SA, et al.: Community energy balance: A framework for contextualizing cultural influences on high risk of obesity in ethnic minority populations, Preventive Medicine, 55(5), 371-381, 2012 https://doi.org/10.1016/j.ypmed.2012.07.002
  6. Pampel FC, Denney JT, Krueger PM : Obesity, SES, and economic development: A test of the reversal hypothesis, Social Science & Medicine, 74(7), 1073-1081, 2012 https://doi.org/10.1016/j.socscimed.2011.12.028
  7. 보건복지부 질병관리본부 : 국민건강영양조사 제5기 2 차년도, 2011
  8. Kissebah AH, Vydelingum N, Murray R, et al. : Relation of body fat distribution to metabolic complication of obesity, J Clin Endocrinol Metab, 54(2), 254-260, 1982 https://doi.org/10.1210/jcem-54-2-254
  9. Despres JP, Lemieux I : Abdominal obesity and metabolic syndrome, Nature, 444(7121), 881-887, 2006 https://doi.org/10.1038/nature05488
  10. Reaven GM : Banting lecture 1988: Role of insulin resistance in human disease, Diabetes, 37(12), 1595-1607, 1988 https://doi.org/10.2337/diab.37.12.1595
  11. Pyorala M, Miettinen H, Halonen P, Laakso M, Pyorala K : Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow- up results of the Helsinki Policemen Study, Arterioscler Thromb Vasc Biol, 20(2), 538-544, 2000 https://doi.org/10.1161/01.ATV.20.2.538
  12. Bjorntorp P : "Potal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes, Arteriosclerosis, 10(4), 493-496, 1990 https://doi.org/10.1161/01.ATV.10.4.493
  13. Garg A : Insulin resistance in the pathogenesis of dyslipidemia, Diabetes Care, 19(4), 387-389, 1996 https://doi.org/10.2337/diacare.19.4.387
  14. Boden G : Fatty acids and insulin resistance, Diabetes Care, 19(4), 394-95, 1996 https://doi.org/10.2337/diacare.19.4.394
  15. Storlien LH, Pan DA, Kirketos AD, et al. : Skeletal muscle membrane lipids and insulin resistance, Lipids, 31, 261-265, 1996 https://doi.org/10.1007/BF02529872
  16. Das UN : Obesity: Genes, brain, gut, and environment, Nutrition, 26(5), 459-473, 2010 https://doi.org/10.1016/j.nut.2009.09.020
  17. Friedman JM : Abnomal splicing of the leptin receptor in diabetic mice, Nature, 379(6566), 632-635, 1996 https://doi.org/10.1038/379632a0
  18. Kadowaki T, Yamauch T, Kubota N : The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS, FEBS Letters, 582(1), 74-80, 2008 https://doi.org/10.1016/j.febslet.2007.11.070
  19. Ahima RS : Cetral actions of adipocytes hormones, Trands Endocrinol Metab, 16(7), 307-313, 2005 https://doi.org/10.1016/j.tem.2005.07.010
  20. Lam KS, Xu A : Adiponectin: protectionof the endothelium, Curr Diab Rep, 5(4), 254-259, 2005 https://doi.org/10.1007/s11892-005-0019-y
  21. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ : Plasma resistin, adiponectin and leptin level in lean and obese subjects: correlation with insulin resistance, Eur J Endocrinol, 149(4), 331-335, 2003 https://doi.org/10.1530/eje.0.1490331
  22. Davies AM : The role of neurotrophins in the developing nervous system, J Neutrobiol, 25(11), 1334-1348, 1994 https://doi.org/10.1002/neu.480251103
  23. McAllister AK : Neurotrophins and neuronal differentiation in the central nervous system, Cell Mol Life Sci, 58(8), 1054-1060, 2001 https://doi.org/10.1007/PL00000920
  24. Lebrun B, Bariohay B, Moyse E, Jean A : Brain-derived neurotrophic factor(BDNF) and food intake regulation: A minireview, Auto Neuroscience, 126, 30-38, 2006
  25. NCEP-ATPIII : Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults(Adults Treatment Panel III(2002) final report, Circulation, 106, 3143-3421, 2002
  26. Merino-Ibarra E, Artieda M, Cenarro A, et al. : Ultrasonography for the evaluation of visceral fat and the metabolic syndrome, Metab Clin Experimental, 54(9), 1230-1235, 2005 https://doi.org/10.1016/j.metabol.2005.04.009
  27. 이현진 : 보건소 비만 프로그램을 통한 성인 여성의 체지방 변화에 따른 건강 상태 및 식생활 비교, 단국 대학원 석사논문, 2007
  28. Chen H, Hansen MJ, Jones JE, et al. : Regulation of hypothalamic NPY by diet and smoking, Peptide, 28, 384-389, 2007 https://doi.org/10.1016/j.peptides.2006.07.034
  29. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L : Endogenous glucose production is inhibited by the adipose-derived protein Acrp30, J Clin Invest 108(21), 1875-1881, 2001 https://doi.org/10.1172/JCI14120
  30. Duncan BB, Schmidt MI, Pankow JS, et al. : Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study, Diabetes, 53(9), 2473-2478, 2004 https://doi.org/10.2337/diabetes.53.9.2473
  31. Tschritter O, Fritsche A, Thamer C, et al. : Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism, Diabetes, 52(2), 239-243, 2003 https://doi.org/10.2337/diabetes.52.2.239
  32. Maffei M, Halaas J, Ravussin E, et al. : Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects, Nat Med, 1(11), 1155-1161, 1995 https://doi.org/10.1038/nm1195-1155
  33. Considine RV, Sinha MK, Heiman ML, et al. : Serum immunoreactive -leptin concentrations in normal-weight and obese humans, N Engl J Med, 334(5), 292-295, 1996 https://doi.org/10.1056/NEJM199602013340503
  34. Ono M, Itakura Y, Nonomura T, et al. : Intermittent administration of brain-derived neurotrophic factor ameliorates glucose metabolism in obese diabetic mice, metabolism, 49(1), 129-133, 2000 https://doi.org/10.1016/S0026-0495(00)90988-0
  35. Ahima RS, Jeffery SF : Adipose tissue as an endocrine organ, Trands Endocrinol Metab, 11(8), 327-332, 2000 https://doi.org/10.1016/S1043-2760(00)00301-5
  36. Minocci A, Savia G, Lucantoni R, et al. : Leptin plasma concentrations are dependent on body fat distribution in obese patients, Int J Obese Relat Metab Disord, 24(9), 1139-1144, 2000 https://doi.org/10.1038/sj.ijo.0801385
  37. Koebnick C, Shaibi GQ, Kelly LA, et al. : Leptin-to-adiponectin ratio as independent predictor of insulin sensitivity during growth in overweight Hispanic youth, J Endocrinol Invest, 30(7), RC13-6, 2007 https://doi.org/10.1007/BF03346344
  38. Kwon K, Jung SH, Choi C, Park S-H : Reciprocal association between visceral obesity and adiponectin: in healthy premenopausal women, Int J Cardiology, 101(3), 385-390, 2005 https://doi.org/10.1016/j.ijcard.2004.03.050
  39. Park K-G, Park KS, Kim M-J, et al. : Relationship between serum adiponectin and leptin concentrations and body fat distribution, Diabetes Res Clin Practice, 63(2), 135-142, 2004 https://doi.org/10.1016/j.diabres.2003.09.010
  40. Guzik TJ, Mangalat D, Korbut R : Adipocytokines-novel link between inflammation and vascular function?, J Physiol Pharmacol, 57(4), 505-528, 2006